Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Altamira Therapeutics Ltd CYTOF

Healthcare Biotechnology
Altamira Therapeutics Ltd. is a Bermuda-based company engaged in developing ribonucleic acid (RNA)-based therapeutics for extrahepatic targets (OligoPhore/SemaPhore delivery platforms). The Company has two flagship short interfering (siRNA) programs in preclinical development beyond in vivo proof of concept: AM-401 for KRAS driven cancer and AM-411 for rheumatoid arthritis. The delivery... see more

Recent & Breaking News (OTCQB:CYTOF)

Auris Medical to Present at the Jefferies 2016 Healthcare Conference on Thursday, June 9

GlobeNewswire June 2, 2016

Auris Medical Provides Business Update and Reports First Quarter 2016 Financial Results

GlobeNewswire May 11, 2016

Auris Medical to Announce First Quarter 2016 Financial Results and Host Conference Call on Wednesday, May 11, 2016

GlobeNewswire May 4, 2016

Auris Medical to Present at the 15th Annual Needham Healthcare Conference on Tuesday, April 12

GlobeNewswire April 5, 2016

Auris Medical Completes Enrollment of TACTT2 Phase 3 Trial of AM-101 in Acute Inner Ear Tinnitus

GlobeNewswire March 30, 2016

Auris Medical Provides Business Update and Reports Fourth Quarter and Full Year 2015 Financial Results

GlobeNewswire March 14, 2016

Auris Medical to Announce Fourth Quarter and Full Year 2015 Financial Results and Host Conference Call on Monday, March 14, 2016

GlobeNewswire March 2, 2016

Auris Medical to Host Key Opinion Leader Meeting and Webcast Focused on Acute Sensorineural Hearing Loss on February 26 in New York City

GlobeNewswire February 18, 2016

Auris Medical to Present at the 2016 Leerink Global Healthcare Conference on Thursday, February 11

GlobeNewswire February 5, 2016

Pharma Industry Poised for Fast Start in 2016 as U.S. Food & Drug Administration Receives Requests for Newest Orphan Drug Designations & Rare Disease Treatments

Press Releases December 29, 2015

Auris Medical Announces Enrollment of First Patient in HEALOS Study of AM-111 in Treatment of Idiopathic Sudden Sensorineural Hearing Loss

GlobeNewswire November 13, 2015

Auris Medical AG : Auris Medical Holding AG Reports Third Quarter 2015 Financial Results and Provides Business Update

GlobeNewswire November 12, 2015

Auris Medical to Announce Third Quarter 2015 Financial Results and Host Conference Call on Thursday, November 12, 2015

GlobeNewswire November 5, 2015

Auris Medical and King's College London Collaborate in Drug Discovery for Second Generation Tinnitus Treatment

GlobeNewswire October 23, 2015

Auris Medical to Host Corporate Symposium on Rational Pharmacotherapy for Acute Hearing Loss on September 28, 2015

GlobeNewswire September 25, 2015

Auris Medical to Present at the Leerink Partners 4th Annual Rare Disease Roundtable on Wednesday, September 30, 2015

GlobeNewswire September 23, 2015

Auris Medical Holding AG Reports Second Quarter 2015 Financial Results and Provides Business Update

GlobeNewswire August 19, 2015

Auris Medical to Announce Second Quarter 2015 Financial Results and Host Conference Call on Wednesday, August 19, 2015

GlobeNewswire August 12, 2015

Auris Medical Promotes Anne Sabine Zoller to General Counsel

GlobeNewswire August 3, 2015

Auris Medical Holding AG Provides Update on U.S. Intellectual Property Portfolio

GlobeNewswire July 2, 2015